NanoVibronix Ltd. performs R&D, manufacturing and marketing of its products and is a subsidiary of NanoVibronix Inc. – located in Elmsford, NY.
The company is publicly traded in NASDAQ (NAOV).
NanoVibronix’s technology consists of a unique, miniature transducer technology that transmits low-frequency, low-intensity ultrasound onto treatment surface. These small, thin and lightweight transducers create Surface Acoustic Waves reaching up to 10 cm from the transducer. These unique properties allow the creation of a small, self-adhering acoustic patch that contains the transducer and administers the ultrasound. This application revolutionizes the administration ultrasound for therapeutic clinical applications, encouraging patients’ independence; promoting clinician supervised home based care and reducing the cost of therapy. Applications using this technology include pain, soft tissue healing and wound treatment.
The technology allows converting indwelling catheters into active acoustic disease-fighting devices. Certain catheters often pose a risk of biofilm and infection as well as a risk of trauma and discomfort. NanoVibronix devices attached to catheters reduce catheter-acquired infection, antibiotic usage and bacterial resistance and therapeutically treat catheter-associated injury.
PainShield™ – ultrasound therapy for pain relief, soft tissue healing and non-union fractures.
UroShield™ – diminishes biofilm formation on urinary catheters and prevents UTI, increases antibiotic efficacy and decreases pain and discomfort associated with urinary catheter use.
WoundShield™ – increases tissue oxygenation for accelerated healing of chronic and acute wounds.